The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The six studies that examined all-cause death and the 13 on diabetes-related death showed consistent increases in both.
The findings could help inform real-time guidance, as ongoing scientific study continues.
Discordant findings on Paxlovid and long COVID illustrate why more trials are needed.
Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines.
Wastewater estimates suggest that clinical cases underestimate the true burden by a factor of 2- to 19-fold.
Signs are encouraging, though activity sometimes rises again after the holiday period.
The protein changes suggest a significant alteration of the complement system, which results in the immune system remaining activated and inflamed.
Whole-genome sequencing of samples from the animals revealed four novel mutations not found in public databases as of November 2023.
Reducing obstacles to care, speeding up drug trials, improving resources for clinicians, and preventing virus spread were among many improvements witnesses discussed.
The length of COVID-19 symptoms was on average 36 hours shorter in the simnotrelvir group.
